These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 7841853)
41. Norepinephrine and stimulant addiction. Sofuoglu M; Sewell RA Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678 [TBL] [Abstract][Full Text] [Related]
42. Monoamines and abnormal behaviour. A multi-aminergic perspective. van Praag HM; Asnis GM; Kahn RS; Brown SL; Korn M; Friedman JM; Wetzler S Br J Psychiatry; 1990 Nov; 157():723-34. PubMed ID: 1980627 [TBL] [Abstract][Full Text] [Related]
43. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction. Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806 [TBL] [Abstract][Full Text] [Related]
44. Neurobiological mechanisms in cocaine and opiate dependence. Koob GF Res Publ Assoc Res Nerv Ment Dis; 1992; 70():79-92. PubMed ID: 1311123 [No Abstract] [Full Text] [Related]
46. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. Svetlov SI; Kobeissy FH; Gold MS J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226 [TBL] [Abstract][Full Text] [Related]
47. Drug abuse: hedonic homeostatic dysregulation. Koob GF; Le Moal M Science; 1997 Oct; 278(5335):52-8. PubMed ID: 9311926 [TBL] [Abstract][Full Text] [Related]
48. The complexity of the dopaminergic synapses and their modulation by antipsychotics. Leuner K; Müller WE Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891 [TBL] [Abstract][Full Text] [Related]
49. Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Westerink BH; Damsma G; Rollema H; De Vries JB; Horn AS Life Sci; 1987 Oct; 41(15):1763-76. PubMed ID: 2889121 [TBL] [Abstract][Full Text] [Related]
50. Neurochemical mechanisms underlying responses to psychostimulants. Volkow ND; Fowler JS; Hitzemann R; Wang GJ NIDA Res Monogr; 1996; 159():322-48. PubMed ID: 8784863 [No Abstract] [Full Text] [Related]
52. [Biological aspects of the development of drug dependence]. Feuerlein W Med Monatsschr Pharm; 1992 Mar; 15(3):73-5. PubMed ID: 1349152 [No Abstract] [Full Text] [Related]
53. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Gasior M; Bergman J; Kallman MJ; Paronis CA Neuropsychopharmacology; 2005 Apr; 30(4):758-64. PubMed ID: 15526000 [TBL] [Abstract][Full Text] [Related]
54. Agents in development for the management of cocaine abuse. Gorelick DA; Gardner EL; Xi ZX Drugs; 2004; 64(14):1547-73. PubMed ID: 15233592 [TBL] [Abstract][Full Text] [Related]
55. Overview: biological processes relevant to drugs of dependence. Grunberg NE Addiction; 1994 Nov; 89(11):1443-6. PubMed ID: 7841854 [TBL] [Abstract][Full Text] [Related]
56. Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence. Extein IL; Gold MS J Addict Dis; 1993; 12(3):29-43. PubMed ID: 7504527 [TBL] [Abstract][Full Text] [Related]
57. New perspectives on cocaine addiction: recent findings from animal research. Bozarth MA Can J Physiol Pharmacol; 1989 Sep; 67(9):1158-67. PubMed ID: 2688864 [TBL] [Abstract][Full Text] [Related]
58. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. Schmitt KC; Reith ME Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860 [TBL] [Abstract][Full Text] [Related]
59. The role of neurotransmitters in alcohol dependence: animal research. De Witte P Alcohol Alcohol; 1996 Mar; 31 Suppl 1():13-6. PubMed ID: 8736996 [TBL] [Abstract][Full Text] [Related]
60. Cocaine reward and cocaine craving: the role of dopamine in perspective. Wise RA NIDA Res Monogr; 1994; 145():191-206. PubMed ID: 8742814 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]